Ginkgo Bioworks DNA Operating Lease Right-of-Use Assets in Other Assets
Operating Lease Right-of-Use Assets in Other Assets at other companies
Other financials
Where this comes from
Reported directly by Ginkgo Bioworks in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The official record: Ginkgo Bioworks’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ginkgo Bioworks's operating lease right-of-use assets in other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ginkgo Bioworks's operating lease right-of-use assets in other assets?
- Ginkgo Bioworks (DNA) reported operating lease right-of-use assets in other assets of $353.8M in Q1 2026.
- How has Ginkgo Bioworks's operating lease right-of-use assets in other assets changed year-over-year?
- Ginkgo Bioworks's operating lease right-of-use assets in other assets decreased by 7.7% year-over-year, from $383.39M to $353.8M.